Business Context and Reporting Period
The filing is a Form 10-Q for the quarter ended September 30, 2017, filed by Ambac Financial Group, Inc. The request metadata names OCTAVE SPECIALTY GROUP INC., but the provided filing text identifies Ambac Financial Group, Inc. as the registrant. Ambac provides financial guarantee insurance through Ambac Assurance Corporation and Ambac Assurance UK Limited. The insurance portfolio is in runoff, and the company has not written new financial guarantee business since 2008.
Beginning in the second quarter of 2017, management reported one consolidated operating segment following the substantial wind-down of its financial services activities.
Financial Performance and Position
| Metric | Three Months Ended September 30, 2017 | Prior Comparable Period | Nine Months Ended September 30, 2017 | Prior Comparable Period |
|---|---|---|---|---|
| Net premiums earned | $53.0 million | $53.2 million | $143.8 million | $147.4 million |
| Net investment income | $87.2 million | $90.9 million | $253.9 million | $222.5 million |
| Total revenues | $133.0 million | $145.0 million | $432.0 million | $268.7 million |
| Losses and loss expenses | $209.8 million expense | $69.2 million benefit | $410.9 million expense | $227.0 million benefit |
| Operating expenses | $33.8 million | $21.5 million | $92.8 million | $77.5 million |
| Net income attributable to common shareholders | $(190.9) million | $101.5 million | $(309.2) million | $169.5 million |
| Diluted loss per share | $(4.20) | $2.22 income per share | $(6.82) | $3.74 income per share |
- Total assets were $23.3 billion at September 30, 2017, compared with $22.6 billion at December 31, 2016.
- Total stockholders’ equity was $1.77 billion, down from $1.98 billion at year-end 2016. Ambac Financial Group stockholders’ equity was $1.51 billion.
- Investments totaled $6.23 billion, including $4.98 billion of fixed-income securities, $716.5 million of short-term investments and $440.0 million of other investments.
- Cash and cash equivalents were $107.0 million, compared with $91.0 million at December 31, 2016.
- Long-term debt was $988.1 million, excluding $12.23 billion of long-term debt reported within consolidated variable interest entities.
- Loss and loss expense reserves increased to $4.70 billion from $4.38 billion, while subrogation recoverable increased to $703.9 million from $684.7 million.
- Operating cash flow was $(278.7) million for the first nine months of 2017, compared with $825.5 million provided in the prior-year period. Investing activities provided $474.1 million, financing activities used $177.8 million, and ending cash increased by $16.0 million.
- Adjusted earnings were $(149.8) million for the quarter and $(170.6) million for the nine months. Adjusted book value was $1.11 billion, or $24.56 per share, compared with $1.33 billion, or $29.48 per share, at December 31, 2016.
Material Changes Versus Prior Comparable Period
- The company moved from profitability to a substantial loss. The principal driver was a $209.8 million quarterly loss expense versus a $69.2 million benefit in the third quarter of 2016. Nine-month loss expenses were $410.9 million versus a $227.0 million benefit in 2016.
- Domestic public finance losses were $212.5 million in the quarter and $434.1 million for the nine months, largely reflecting adverse development in Puerto Rico and military housing exposures.
- Net investment income increased $31.4 million for the nine-month period, while net gains on interest-rate derivatives improved by $170.8 million, primarily because of the June 2017 Augusta swap commutation.
- Net other-than-temporary impairment losses were $13.5 million in the quarter and $19.2 million for the nine months. Net realized investment gains declined to $5.4 million for the nine months from $27.7 million.
- Total net insured par outstanding declined 16% to $66.7 billion from $79.3 billion at December 31, 2016. Below-investment-grade exposure declined to $14.4 billion from $16.8 billion.
- Operating expenses increased due to legal, consulting and advisory costs associated with the rehabilitation exit plan, litigation contingencies, severance and incentive compensation. The company reduced its employee base by approximately 19% since December 31, 2016 and expects approximately $8.5 million of annual compensation savings.
- Derivative liabilities declined to $90.9 million from $319.3 million, primarily due to terminated interest-rate swaps and the application of $71.0 million of variation margin as a reduction of derivative liabilities.
Guidance, Outlook, Risks and Unusual Items
Management did not provide conventional earnings guidance. Its strategy is focused on actively running off Ambac Assurance, reducing insured exposures, pursuing commutations and restructurings, maximizing investment returns, recovering losses through litigation and evaluating adjacent business opportunities.
- Going concern: Management concluded that substantial doubt exists about Ambac’s ability to continue as a going concern because of uncertainty regarding oversight of the Segregated Account and the company’s ability to realize value from Ambac Assurance. The financial statements nevertheless assume continued operation and contain no going-concern adjustment.
- Rehabilitation Exit Transactions: The proposed transaction would exchange certain surplus notes and satisfy Deferred Amounts using cash, new secured notes and existing surplus notes, with the objective of exiting Segregated Account rehabilitation. The expected cash outflow was approximately $1.3 billion. Court, regulatory, holder-consent, participation, tax and capital conditions remained outstanding.
- Tier 2 financing: Ambac Assurance entered into a commitment for $240 million of senior notes secured by litigation proceeds above $1.6 billion. There was no assurance that the notes would be issued.
- Puerto Rico: Ambac had approximately $1.97 billion of Puerto Rico net par exposure and recorded $434.1 million of domestic public finance losses for the nine months. Title III proceedings, proposed fiscal plans, the Fiscal Plan Compliance Act and Hurricane Maria created substantial uncertainty regarding recoveries and future claims.
- Management estimated possible additional loss reserves of approximately $1.5 billion for public finance exposures under stress, approximately $1.9 billion for RMBS if estimated representation-and-warranty recoveries were unavailable, approximately $100 million for student loans and approximately $300 million for other credits, including Ambac UK. Actual losses could exceed these estimates.
- Recorded representation-and-warranty subrogation recoveries were $1.84 billion. Recoverability depends on litigation outcomes, counterparties’ ability to pay, regulatory intervention and assumptions regarding collateral performance.
- Ambac UK had a statutory capital deficiency under Solvency II of approximately £312.5 million based on the latest available June 30, 2017 information. September 30, 2017 Solvency II results were not yet finalized in the filing.
- The filing identifies material exposure to interest-rate, credit-spread and foreign-currency risk, as well as military housing, student loan, RMBS and public finance concentration risk.
Most Important Facts for Investors to Verify
- Confirm that the intended registrant is Ambac Financial Group, Inc., not OCTAVE SPECIALTY GROUP INC.
- Track the status and final terms of the Segregated Account Rehabilitation Exit Transactions, including court approval, OCI approval, holder participation, tax rulings, capital sufficiency and the proposed $1.3 billion cash requirement.
- Monitor Puerto Rico Title III proceedings, revised fiscal plans, Hurricane Maria recovery, related litigation and the effect on reserves, liquidity and statutory capital.
- Reconcile reported loss reserves of $4.70 billion with the company’s projected stress ranges and assess the sensitivity to reduced RMBS recoveries.
- Assess Ambac Assurance’s statutory surplus, dividend restrictions and ability to provide liquidity or tolling payments to the holding company.
- Review Ambac UK’s finalized Solvency II capital position and any regulatory remediation plan.
- Distinguish GAAP results from management’s non-GAAP adjusted earnings and adjusted book value, particularly the effects of insurance-intangible amortization, foreign exchange and fair-value adjustments.